{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:09:52Z","timestamp":1780920592674,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006484","name":"Vifor Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinejcf.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.cardfail.2026.04.011","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:42:39Z","timestamp":1778758959000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proton-Pump Inhibitor Use as a Modifiable Etiological Factor for Iron Deficiency in Heart Failure"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2985-1420","authenticated-orcid":false,"given":"MATS","family":"KUTSCHER","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HAYE H. VAN DER","family":"WAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ADRIAAN A.","family":"VOORS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PETER VAN DER","family":"MEER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NIELS","family":"GROTE\u202fBEVERBORG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cardfail.2026.04.011_bib0001","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11010125","article-title":"Iron deficiency in heart failure: mechanisms and pathophysiology","volume":"11","author":"Alnuwaysir","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.04.011_bib0002","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1093\/eurheartj\/ehz680","article-title":"Iron deficiency in worsening heart failure is associated with reduced estimated protein intake, fluid retention, inflammation, and antiplatelet use","volume":"40","author":"van der Wal","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.04.011_bib0003","doi-asserted-by":"crossref","first-page":"4901","DOI":"10.1093\/eurheartj\/ehab670","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2026.04.011_bib0004","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.3390\/jcm8091382","article-title":"Chronic use of proton-pump inhibitors and iron status in renal transplant recipients","volume":"8","author":"Douwes","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/j.cardfail.2026.04.011_bib0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/joim.12826","article-title":"Use of proton pump inhibitors and risk of iron deficiency: a population-based case-control study","volume":"285","author":"Tran-Duy","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/j.cardfail.2026.04.011_bib0006","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/ejhf.531","article-title":"A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHF","volume":"18","author":"Voors","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2026.04.011_bib0007","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00228-008-0576-5","article-title":"Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH","volume":"65","author":"Kirchheiner","year":"2009","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2026.04.011_bib0008","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.toxlet.2019.10.016","article-title":"Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway","volume":"318","author":"Hamano","year":"2020","journal-title":"Toxicol Lett"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916426002307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916426002307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T11:37:41Z","timestamp":1780918661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916426002307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":8,"alternative-id":["S1071916426002307"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.04.011","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Proton-Pump Inhibitor Use as a Modifiable Etiological Factor for Iron Deficiency in Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiac Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cardfail.2026.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}